ALNY ▲ +0.8% - Alnylam Pharmaceuticals, Inc. $ALNY Alnylam Collaborator Regeneron Secures FDA Approval of Livsayis™ (cemdisiran), the Seventh FDA-Approved Therapeutic from Alnylam's RNAi Platform in Less Than Nine Years 19-NOV-2026 07:02 AM ET